SCHEMBL587239

SCHEMBL587239

C=CCONc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.40
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALOX15 P16050 2/20 0.39
TSHR P16473 2/20 0.39
ALOX12 P18054 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
MAPK1 P28482 1/20 0.39
PTGS2 P35354 1/20 0.39
HTR2B P41595 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP1A2 P05177 2/20 0.38
TGM2 P21980 1/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LIG1 P18858 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL942986 0.78 ALDH1A1 (0.43) HSD17B10ALDH1A1L3MBTL1TDP1ALOX15
SCHEMBL11318079 0.75 TSHR (0.34) HSD17B10ALDH1A1L3MBTL1TDP1ALOX15
SCHEMBL9090785 0.75 TSHR (0.34) HSD17B10ALDH1A1L3MBTL1TDP1ALOX15
SCHEMBL27497360 0.75 CYP1B1 (0.40) ALDH1A1TSHRMAPK1MAPTMEN1
SCHEMBL28187507 0.74 HTT (0.38) HSD17B10ALDH1A1L3MBTL1TDP1ALOX15
SCHEMBL716309 0.72 ALDH1A1 (0.54) HSD17B10ALDH1A1L3MBTL1TDP1ALOX15
SCHEMBL11311334 0.71 TGM2 (0.32) ALDH1A1TSHRCYP3A4CYP1A2TGM2
SCHEMBL10433957 0.71 RAPGEF4 (0.39) HSD17B10ALDH1A1L3MBTL1TSHRPTGS2
SCHEMBL7110909 0.71 SMN1; SMN2 (0.47) ALDH1A1L3MBTL1TDP1ALOX15TSHR
SCHEMBL4945888 0.71 CYP1A2 (0.40) ALDH1A1CYP1A2TGM2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128734-A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases FLOERSHEIMER ANDREAS 2006-06-15 US claimed
EP-0287478-B1 PROCESS FOR PREPARING AROMATIC DIAMINES CONTAINING POLYDIORGANOSILOXANE GROUPS RHONE-POULENC CHIMIE (FR) 1992-05-13 EP claimed
US-4948858-A Preparation of diorganopolysiloxylated diamines RHONE-POULENC CHIMIE (FR) 1990-08-14 US claimed
EP-0287478-A1 Process for preparing aromatic diamines containing polydiorganosiloxane groups RHONE-POULENC CHIMIE (FR) 1988-10-19 EP claimed
EP-0271170-A2 Herbicidal substituted benzofurans and benzopyrans SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-06-15 EP claimed
CN-111511750-B Macrocyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2023-06-13 CN disclosed
US-20220387602-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE NOVARTIS AG (CH) 2022-12-08 US disclosed
CN-114940692-A Compound with anti-lung cancer effect and preparation method and application thereof 重庆文理学院 2022-08-26 CN disclosed
EP-4031247-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE Novartis AG (CH) 2022-07-27 EP disclosed
CN-114521196-A Bifunctional group degradation agent and use method thereof 诺华股份有限公司 2022-05-20 CN disclosed
EP-2945702-A1 HYDROXY ALIPHATIC SUBSTITUTED PHENYL AMINOALKYL ETHER DERIVATIVES Prous Institute for Biomedical Research, S.A. (ES) 2015-11-25 EP disclosed
WO-2014096377-A1 HYDROXY ALIPHATIC SUBSTITUTED PHENYL AMINOALKYL ETHER DERIVATIVES PROUS INSTITUTE FOR BIOMEDICAL RESEARCH, S.A. (ES) 2014-06-26 WO disclosed
EP-0287478-A1 Process for preparing aromatic diamines containing polydiorganosiloxane groups RHONE-POULENC CHIMIE (FR) 1988-10-19 EP disclosed
US-4777237-A HEAT-RESISTANT THERMOSETTING MOLDING MATERIALS RHONE-POULENC SPECIALITIES CHIMIQUES (FR) 1988-10-11 US disclosed
EP-0284519-A1 Bismaleimide siloxanes and process for their preparation CIBA-GEIGY AG (CH) 1988-09-28 EP disclosed
EP-0284520-A1 Thermally stable polymers based on maleimides, among which a bis-maleimide-siloxane, and processes for their preparation RHONE-POULENC CHIMIE (FR) 1988-09-28 EP disclosed
EP-0284524-A1 Thermostable polymers based on maleimides, of which one is a bismaleimide-siloxane, and on aromatic diamines, and process for their preparation RHONE-POULENC CHIMIE (FR) 1988-09-28 EP disclosed
EP-0271170-A2 Herbicidal substituted benzofurans and benzopyrans SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-06-15 EP disclosed
US-4742141-A HEAT-STABLE; IMPREGNANTS; COATING OR MOLDING RESINS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1988-05-03 US disclosed
US-4128561-A Process for the preparation of 2-(2-thienyl)-ethylamine and derivatives thereof PARCOR (FR) 1978-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220387602-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE JMJD7, MDM2, IDE HSD17B10 1399/4885ALDH1A1 2189/4885L3MBTL1 1534/4885
US-20060128734-A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases UCK2, PRKDC, PRKACA HSD17B10 3272/4885ALDH1A1 3040/4885L3MBTL1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.